In contrast, triple negative cancer subtype (HER-2 (-), ER (-) and PR (-)) represents a worst prognosis in the patients, as no specific treatment is available for this type of cancer with a high-rate of cellular proliferation. This evidence concerns the gene ERBB2 and cancer.